A new program is testing in-utero gene therapy to treat severe inherited diseases before birth. This approach involves carrier screening of parents to identify potential genetic risks, followed by prenatal diagnosis of the fetus. If a treatable condition like GM1 Gangliosidosis is detected, gene therapy can be administered to prevent irreversible harm, particularly to the brain and nervous system, offering a healthier future for affected children. AI
RANK_REASON The item discusses a new study and trial for in-utero gene therapy, which falls under research. [lever_c_demoted from research: ic=1 ai=0.1]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
